{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:42:22Z","timestamp":1795016542977,"version":"4.10.1"},"reference-count":198,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6,23]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The management of acute and chronic pain for individuals living with sickle cell disease (SCD) is a clinical challenge. This reflects the paucity of clinical SCD pain research and limited understanding of the complex biological differences between acute and chronic pain. These issues collectively create barriers to effective, targeted interventions. Optimal pain management requires interdisciplinary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>These evidence-based guidelines developed by the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in pain management decisions for children and adults with SCD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>ASH formed a multidisciplinary panel, including 2 patient representatives, that was thoroughly vetted to minimize bias from conflicts of interest. The Mayo Evidence-Based Practice Research Program supported the guideline development process, including updating or performing systematic reviews. Clinical questions and outcomes were prioritized according to importance for clinicians and patients. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used, including GRADE evidence-to-decision frameworks, to assess evidence and make recommendations, which were subject to public comment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The panel reached consensus on 18 recommendations specific to acute and chronic pain. The recommendations reflect a broad pain management approach, encompassing pharmacological and nonpharmacological interventions and analgesic delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Because of low-certainty evidence and closely balanced benefits and harms, most recommendations are conditional. Patient preferences should drive clinical decisions. Policymaking, including that by payers, will require substantial debate and input from stakeholders. Randomized controlled trials and comparative-effectiveness studies are needed for chronic opioid therapy, nonopioid therapies, and nonpharmacological interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2020001851","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T11:39:27Z","timestamp":1592566767000},"page":"2656-2701","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":448,"title":["American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain"],"prefix":"10.1182","volume":"4","author":[{"given":"Amanda M.","family":"Brandow","sequence":"first","affiliation":[{"name":"Section of Hematology\/Oncology\/Bone Marrow Transplantation, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7511-916X","authenticated-orcid":false,"given":"C. Patrick","family":"Carroll","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Creary","sequence":"first","affiliation":[{"name":"Center for Innovation in Pediatric Practice, Division of Hematology, Oncology and Bone Marrow Transplant, Nationwide Children\u2019s Hospital, The Ohio State University School of Medicine, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronisha","family":"Edwards-Elliott","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Illinois at Chicago, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Glassberg","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Hurley","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and"},{"name":"Department of Public Health Sciences, Wake Forest School of Medicine, Winston Salem, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Kutlar","sequence":"first","affiliation":[{"name":"Center for Blood Disorders, Medical College of Georgia, Augusta University, Augusta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Seisa","sequence":"first","affiliation":[{"name":"Mayo Clinic Evidence-based Practice Research Program, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Stinson","sequence":"first","affiliation":[{"name":"Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0341-1457","authenticated-orcid":false,"given":"John J.","family":"Strouse","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine, and"},{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Duke University School of Medicine, Durham, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouza","family":"Yusuf","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Zempsky","sequence":"first","affiliation":[{"name":"Division of Pain and Palliative Medicine, Connecticut Children\u2019s Medical Center, Department of Pediatrics, University of Connecticut School of Medicine, Hartford, CT; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0850-4337","authenticated-orcid":false,"given":"Eddy","family":"Lang","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,6,19]]},"reference":[{"issue":"6","key":"2020061911392410100_B1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/AJP.0000000000000289","article-title":"Psychosocial and functional outcomes in youth with chronic sickle cell pain","volume":"32","author":"Sil","year":"2016","journal-title":"Clin J Pain"},{"issue":"2","key":"2020061911392410100_B2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Ann Intern Med"},{"issue":"2","key":"2020061911392410100_B3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/ejh.12340","article-title":"Thinking beyond sickling to better understand pain in sickle cell disease","volume":"93","author":"Darbari","year":"2014","journal-title":"Eur J Haematol"},{"key":"2020061911392410100_B4","doi-asserted-by":"crossref","first-page":"134471","DOI":"10.1016\/j.neulet.2019.134471","article-title":"Updated mechanisms underlying sickle cell disease-associated pain","volume":"712","author":"Du","year":"2019","journal-title":"Neurosci Lett"},{"key":"2020061911392410100_B5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/asheducation-2017.1.546","article-title":"Targeting novel mechanisms of pain in sickle cell disease","volume":"2017","author":"Tran","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"2020061911392410100_B6","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1503\/cmaj.131237","article-title":"Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise","volume":"186","author":"Schunemann","year":"2014","journal-title":"CMAJ"},{"key":"2020061911392410100_B7","author":"Graham","year":"2011"},{"issue":"7","key":"2020061911392410100_B8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-156-7-201204030-00009","article-title":"Guidelines International Network: toward international standards for clinical practice guidelines","volume":"156","author":"Qaseem","year":"2012","journal-title":"Ann Intern Med."},{"issue":"7","key":"2020061911392410100_B9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/M14-1885","article-title":"Guidelines International Network: principles for disclosure of interests and management of conflicts in guidelines","volume":"163","author":"Sch\u00fcnemann","year":"2015","journal-title":"Ann Intern Med"},{"key":"2020061911392410100_B10","doi-asserted-by":"crossref","first-page":"i2089","DOI":"10.1136\/bmj.i2089","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"2020061911392410100_B11","doi-asserted-by":"crossref","first-page":"i2016","DOI":"10.1136\/bmj.i2016","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"2020061911392410100_B12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6963-4-38","article-title":"Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches the GRADE Working Group","volume":"4","author":"Atkins","year":"2004","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"2020061911392410100_B13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"7650","key":"2020061911392410100_B14","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"2020061911392410100_B15","first-page":"677","article-title":"Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations","volume":"169","author":"Schunemann","year":"2003","journal-title":"CMAJ"},{"key":"2020061911392410100_B16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jclinepi.2016.01.032","article-title":"GRADE guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health","volume":"76","author":"Sch\u00fcnemann","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2020061911392410100_B17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jclinepi.2016.07.006","article-title":"Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group","volume":"80","author":"Guyatt","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2020061911392410100_B18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jpain.2016.12.016","article-title":"AAPT diagnostic criteria for chronic sickle cell disease pain","volume":"18","author":"Dampier","year":"2017","journal-title":"J Pain"},{"issue":"9","key":"2020061911392410100_B19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The International Classification of Headache Disorders, 3rd edition (beta version)","volume":"33","author":"Headache Classification Committee of the International Headache Society","year":"2013","journal-title":"Cephalalgia"},{"key":"2020061911392410100_B20","author":"Lo","year":"2009"},{"issue":"11","key":"2020061911392410100_B21","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jclinepi.2014.05.006","article-title":"Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: a descriptive study","volume":"67","author":"Akl","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"2020061911392410100_B22","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-152-11-201006010-00254","article-title":"The vexing problem of guidelines and conflict of interest: a potential solution","volume":"152","author":"Guyatt","year":"2010","journal-title":"Ann Intern Med"},{"issue":"6","key":"2020061911392410100_B23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1164\/rccm.200901-0126ST","article-title":"An official American Thoracic Society Policy statement: managing conflict of interest in professional societies","volume":"180","author":"Sch\u00fcnemann","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2020061911392410100_B24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"2020061911392410100_B25","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence\u2014indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"23","key":"2020061911392410100_B26","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1182\/bloodadvances.2019000931","article-title":"2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations","volume":"3","author":"Murad","year":"2019","journal-title":"Blood Adv"},{"issue":"4","key":"2020061911392410100_B27","first-page":"15","article-title":"What the emergency nurse needs to know about sickle cell disease","volume":"2","author":"Powars","year":"1976","journal-title":"J Emerg Nurs"},{"issue":"6","key":"2020061911392410100_B28","first-page":"12","article-title":"Sickle cell anemia\u2014the painful crisis","volume":"4","author":"Linehan","year":"1978","journal-title":"J Emerg Nurs"},{"issue":"9","key":"2020061911392410100_B29","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0196-0644(05)82565-X","article-title":"Analgesic use in the emergency department","volume":"19","author":"Selbst","year":"1990","journal-title":"Ann Emerg Med"},{"issue":"9","key":"2020061911392410100_B30","first-page":"777","article-title":"The role of depression in hospital admissions and emergency treatment of patients with sickle cell disease","volume":"83","author":"Belgrave","year":"1991","journal-title":"J Natl Med Assoc"},{"issue":"8","key":"2020061911392410100_B31","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/00007611-199208000-00005","article-title":"Sickle cell vaso-occlusive pain crisis in adults: alternative strategies for management in the emergency department","volume":"85","author":"Sanders","year":"1992","journal-title":"South Med J"},{"issue":"7","key":"2020061911392410100_B32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jpain.2006.05.004","article-title":"Sickle cell disease related pain: crisis and conflict","volume":"7","author":"Todd","year":"2006","journal-title":"J Pain"},{"issue":"22","key":"2020061911392410100_B33","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1001\/jama.2009.1811","article-title":"Treatment of sickle cell pain: fostering trust and justice","volume":"302","author":"Zempsky","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"2020061911392410100_B34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jemermed.2009.06.003","article-title":"Do children with sickle cell disease receive disparate care for pain in the emergency department?","volume":"39","author":"Zempsky","year":"2010","journal-title":"J Emerg Med"},{"issue":"2","key":"2020061911392410100_B35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajh.24948","article-title":"A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD)","volume":"93","author":"Tanabe","year":"2018","journal-title":"Am J Hematol"},{"issue":"12","key":"2020061911392410100_B36","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/ajh.24534","article-title":"Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease","volume":"91","author":"Brandow","year":"2016","journal-title":"Am J Hematol"},{"issue":"3","key":"2020061911392410100_B37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jemermed.2014.09.009","article-title":"Timely pain management in the emergency department","volume":"48","author":"Patrick","year":"2015","journal-title":"J Emerg Med"},{"issue":"4","key":"2020061911392410100_B38","doi-asserted-by":"crossref","first-page":"e1016","DOI":"10.1542\/peds.2014-3470","article-title":"Improving the management of vaso-occlusive episodes in the pediatric emergency department","volume":"136","author":"Kavanagh","year":"2015","journal-title":"Pediatrics"},{"issue":"8","key":"2020061911392410100_B39","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1553-2712.2010.00779.x","article-title":"Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS), a focus group and decision support tool development project","volume":"17","author":"Tanabe","year":"2010","journal-title":"Acad Emerg Med"},{"issue":"7","key":"2020061911392410100_B40","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jpain.2018.12.003","article-title":"AAAPT diagnostic criteria for acute sickle cell disease pain","volume":"20","author":"Field","year":"2019","journal-title":"J Pain"},{"key":"2020061911392410100_B41","first-page":"239","article-title":"Ketorolac versus meperidine in vaso-oclusive crisis: a study of safety and efficacy","volume":"3","author":"Grisham","year":"1996","journal-title":"Int J Pediatr Hematol Oncol"},{"issue":"4","key":"2020061911392410100_B42","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1001\/archpedi.155.4.496","article-title":"Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness","volume":"155","author":"Beiter","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"2020061911392410100_B43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ajh.2830460108","article-title":"Enhancement of pain control with ketorolac tromethamine in patients with sickle cell vaso-occlusive crisis","volume":"46","author":"Perlin","year":"1994","journal-title":"Am J Hematol"},{"issue":"3","key":"2020061911392410100_B44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00006565-199906000-00004","article-title":"Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis","volume":"15","author":"Hardwick","year":"1999","journal-title":"Pediatr Emerg Care"},{"issue":"18","key":"2020061911392410100_B45","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1182\/blood-2009-06-227330","article-title":"A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults","volume":"114","author":"Bartolucci","year":"2009","journal-title":"Blood"},{"issue":"8","key":"2020061911392410100_B46","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00467-017-3623-6","article-title":"Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis","volume":"32","author":"Baddam","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"2020061911392410100_B47","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM199403173301101","article-title":"High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease","volume":"330","author":"Griffin","year":"1994","journal-title":"N Engl J Med"},{"issue":"1","key":"2020061911392410100_B48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1515\/sjpain-2017-0140","article-title":"Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial","volume":"18","author":"Lubega","year":"2018","journal-title":"Scand J Pain"},{"issue":"2","key":"2020061911392410100_B49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/AJP.0b013e3181b511ab","article-title":"Use of low-dose ketamine infusion for pediatric patients with sickle cell disease-related pain: a case series","volume":"26","author":"Zempsky","year":"2010","journal-title":"Clin J Pain"},{"issue":"2","key":"2020061911392410100_B50","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jpainsymman.2013.03.012","article-title":"The role of a low-dose ketamine-midazolam regimen in the management of severe painful crisis in patients with sickle cell disease","volume":"47","author":"Tawfic","year":"2014","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"2020061911392410100_B51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1213\/XAA.0000000000000624","article-title":"Evaluating the use of ketamine for pain control with sickle cell crisis in pregnancy: a report of 2 cases","volume":"10","author":"Gimovsky","year":"2018","journal-title":"A A Pract"},{"key":"2020061911392410100_B52","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2147\/JPR.S131156","article-title":"Subanesthetic ketamine for pain management in hospitalized children, adolescents, and young adults: a single-center cohort study","volume":"10","author":"Sheehy","year":"2017","journal-title":"J Pain Res"},{"issue":"5","key":"2020061911392410100_B53","first-page":"456","article-title":"Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists","volume":"43","author":"Schwenk","year":"2018","journal-title":"Reg Anesth Pain Med"},{"issue":"5","key":"2020061911392410100_B54","first-page":"521","article-title":"Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists","volume":"43","author":"Cohen","year":"2018","journal-title":"Reg Anesth Pain Med"},{"issue":"6","key":"2020061911392410100_B55","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1097\/MPH.0000000000000026","article-title":"Management of refractory pain in hospitalized adolescents with sickle cell disease: changing from intravenous opioids to continuous infusion epidural analgesia","volume":"36","author":"New","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"2020061911392410100_B56","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1542\/peds.93.2.310","article-title":"Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis","volume":"93","author":"Yaster","year":"1994","journal-title":"Pediatrics"},{"issue":"4","key":"2020061911392410100_B57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-155-4-201108160-00346","article-title":"Comparative effectiveness of pain management interventions for hip fracture: a systematic review","volume":"155","author":"Abou-Setta","year":"2011","journal-title":"Ann Intern Med"},{"key":"2020061911392410100_B58","first-page":"CD000331","article-title":"Epidural versus non-epidural or no analgesia for pain management in labour","volume":"5","author":"Anim-Somuah","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"18","key":"2020061911392410100_B59","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1001\/jama.290.18.2455","article-title":"Efficacy of postoperative epidural analgesia: a meta-analysis","volume":"290","author":"Block","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"2020061911392410100_B60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.1998.tb00989.x","article-title":"The management of crisis in sickle cell disease","volume":"60","author":"Okpala","year":"1998","journal-title":"Eur J Haematol"},{"issue":"1","key":"2020061911392410100_B61","doi-asserted-by":"crossref","first-page":"e26742","DOI":"10.1002\/pbc.26742","article-title":"Variations in pediatric emergency medicine physician practices for intravenous fluid management in children with sickle cell disease and vaso-occlusive pain: a single institution experience","volume":"65","author":"Carden","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"2020061911392410100_B62","first-page":"CD005406","article-title":"Fluid replacement therapy for acute episodes of pain in people with sickle cell disease","volume":"7","author":"Okomo","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2020061911392410100_B63","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jpainsymman.2016.12.351","article-title":"A randomized trial of yoga for children hospitalized with sickle cell vaso-occlusive crisis","volume":"53","author":"Moody","year":"2017","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"2020061911392410100_B64","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0304-3959(79)90009-5","article-title":"Acupuncture: an evaluation in the painful crises of sickle cell anaemia","volume":"7","author":"Co","year":"1979","journal-title":"Pain"},{"issue":"2","key":"2020061911392410100_B65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000205612","article-title":"Transcutaneous electrical nerve stimulation treatment of sickle cell pain crises","volume":"80","author":"Wang","year":"1988","journal-title":"Acta Haematol"},{"issue":"9","key":"2020061911392410100_B66","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/AJP.0000000000000036","article-title":"A retrospective review of acupuncture use for the treatment of pain in sickle cell disease patients: descriptive analysis from a single institution","volume":"30","author":"Lu","year":"2014","journal-title":"Clin J Pain"},{"issue":"10","key":"2020061911392410100_B67","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/jpepsy\/jsp015","article-title":"A randomized controlled trial of massage therapy in children with sickle cell disease","volume":"34","author":"Lemanek","year":"2009","journal-title":"J Pediatr Psychol"},{"issue":"4","key":"2020061911392410100_B68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.NAJ.0000445680.06812.6a","article-title":"Original research: using guided imagery to manage pain in young children with sickle cell disease","volume":"114","author":"Dobson","year":"2014","journal-title":"Am J Nurs"},{"issue":"6","key":"2020061911392410100_B69","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/jan.12895","article-title":"A randomized controlled pilot study feasibility of a tablet-based guided audio-visual relaxation intervention for reducing stress and pain in adults with sickle cell disease","volume":"72","author":"Ezenwa","year":"2016","journal-title":"J Adv Nurs"},{"issue":"4","key":"2020061911392410100_B70","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF01000558","article-title":"Management of pain in sickle cell disease using biofeedback therapy: a preliminary study","volume":"9","author":"Thomas","year":"1984","journal-title":"Biofeedback Self Regul"},{"issue":"2","key":"2020061911392410100_B71","doi-asserted-by":"crossref","first-page":"e27525","DOI":"10.1002\/pbc.27525","article-title":"Virtual reality as complementary pain therapy in hospitalized patients with sickle cell disease","volume":"66","author":"Agrawal","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"2020061911392410100_B72","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cpr.2010.07.001","article-title":"The effectiveness of virtual reality distraction for pain reduction: a systematic review","volume":"30","author":"Malloy","year":"2010","journal-title":"Clin Psychol Rev"},{"issue":"26","key":"2020061911392410100_B73","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1080\/09638288.2018.1485183","article-title":"Managing limb pain using virtual reality: a systematic review of clinical and experimental studies","volume":"41","author":"Wittkopf","year":"2019","journal-title":"Disabil Rehabil"},{"issue":"7","key":"2020061911392410100_B74","doi-asserted-by":"crossref","first-page":"e0200987","DOI":"10.1371\/journal.pone.0200987","article-title":"Clinical efficacy of virtual reality for acute procedural pain management: a systematic review and meta-analysis","volume":"13","author":"Chan","year":"2018","journal-title":"PLoS One"},{"key":"2020061911392410100_B75","first-page":"40","article-title":"Scientific evidence for the effectiveness of virtual reality for pain reduction in adults with acute or chronic pain","volume":"144","author":"Shahrbanian","year":"2009","journal-title":"Stud Health Technol Inform"},{"issue":"5","key":"2020061911392410100_B76","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.hrtlng.2017.05.005","article-title":"The effect of massage on acute postoperative pain in critically and acutely ill adults post-thoracic surgery: systematic review and meta-analysis of randomized controlled trials","volume":"46","author":"Boitor","year":"2017","journal-title":"Heart Lung"},{"issue":"1","key":"2020061911392410100_B77","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5935\/1678-9741.20120012","article-title":"Transcutaneous electrical nerve stimulation after thoracic surgery: systematic review and meta-analysis of 11 randomized trials [in English, Portuguese]","volume":"27","author":"Sbruzzi","year":"2012","journal-title":"Rev Bras Cir Cardiovasc"},{"issue":"37","key":"2020061911392410100_B78","doi-asserted-by":"crossref","first-page":"e8036","DOI":"10.1097\/MD.0000000000008036","article-title":"Transcutaneous electrical nerve stimulation for postoperative pain control after total knee arthroplasty: a meta-analysis of randomized controlled trials","volume":"96","author":"Li","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2020061911392410100_B79","doi-asserted-by":"crossref","first-page":"e0150367","DOI":"10.1371\/journal.pone.0150367","article-title":"The efficacy of acupuncture in post-operative pain management: a systematic review and meta-analysis","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"2020061911392410100_B80","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ajh.23912","article-title":"Intensive management of high-utilizing adults with sickle cell disease lowers admissions","volume":"90","author":"Koch","year":"2015","journal-title":"Am J Hematol"},{"issue":"5","key":"2020061911392410100_B81","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/ajh.23961","article-title":"Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis","volume":"90","author":"Lanzkron","year":"2015","journal-title":"Am J Hematol"},{"issue":"1","key":"2020061911392410100_B82","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajem.2017.07.037","article-title":"Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit","volume":"36","author":"Molokie","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"1","key":"2020061911392410100_B83","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/pbc.21483","article-title":"Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital","volume":"51","author":"Raphael","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2020061911392410100_B84","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V95.4.1130.003k03a_1130_1136","article-title":"Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises","volume":"95","author":"Benjamin","year":"2000","journal-title":"Blood"},{"issue":"6","key":"2020061911392410100_B85","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1365-2141.2004.05123.x","article-title":"Day case management of sickle pain: 3 years experience in a UK sickle cell unit","volume":"126","author":"Wright","year":"2004","journal-title":"Br J Haematol"},{"issue":"6","key":"2020061911392410100_B86","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3324\/haematol.10757","article-title":"Effectiveness of a dedicated day hospital for management of acute sickle cell pain","volume":"92","author":"Adewoye","year":"2007","journal-title":"Haematologica"},{"issue":"3","key":"2020061911392410100_B87","first-page":"252","article-title":"A survey of the pain management of acute painful crisis among patients with sickle cell disease at two centres in Jamaica","volume":"63","author":"Augier","year":"2014","journal-title":"West Indian Med J"},{"issue":"1","key":"2020061911392410100_B88","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/cem.2017.413","article-title":"An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization","volume":"21","author":"Binding","year":"2019","journal-title":"CJEM"},{"issue":"2","key":"2020061911392410100_B89","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/1740774513475850","article-title":"IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies","volume":"10","author":"Dampier","year":"2013","journal-title":"Clin Trials"},{"issue":"1","key":"2020061911392410100_B90","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5055\/jom.2010.0004","article-title":"The effect of intravenous opioid patient-controlled analgesia with and without background infusion on respiratory depression: a meta-analysis","volume":"6","author":"George","year":"2010","journal-title":"J Opioid Manag"},{"issue":"4","key":"2020061911392410100_B91","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1213\/ANE.0000000000001244","article-title":"Patient-controlled analgesia plus background opioid infusion for postoperative pain in children: a systematic review and meta-analysis of randomized trials","volume":"123","author":"Hayes","year":"2016","journal-title":"Anesth Analg"},{"issue":"2","key":"2020061911392410100_B92","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/ALN.0b013e31818ec946","article-title":"Practice guidelines for the prevention, detection, and management of respiratory depression associated with neuraxial opioid administration","volume":"110","author":"Horlocker","year":"2009","journal-title":"Anesthesiology"},{"issue":"4","key":"2020061911392410100_B93","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/03630269.2013.789968","article-title":"Leg ulcers in sickle cell disease: current patterns and practices","volume":"37","author":"Delaney","year":"2013","journal-title":"Hemoglobin"},{"issue":"21","key":"2020061911392410100_B94","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.1379.1379","article-title":"Prevalence of symptomatic avascular necrosis and the operative treatment in adult patients with sickle cell disease [abstract]","volume":"124","author":"Blinder","year":"2014","journal-title":"Blood"},{"key":"2020061911392410100_B95","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40164-017-0078-1","article-title":"Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritis","volume":"6","author":"Brandalise","year":"2017","journal-title":"Exp Hematol Oncol"},{"issue":"2","key":"2020061911392410100_B96","first-page":"82","article-title":"Effect of sodium salicylate iontophoresis in the management of hip pain in patients with sickle cell disease","volume":"17","author":"Odebiyi","year":"2007","journal-title":"Nig Q J Hosp Med"},{"issue":"6","key":"2020061911392410100_B97","doi-asserted-by":"crossref","first-page":"534","DOI":"10.7326\/0003-4819-111-6-534","article-title":"Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta thalassemia: a pilot study","volume":"111","author":"Cacciola","year":"1989","journal-title":"Ann Intern Med"},{"issue":"1","key":"2020061911392410100_B98","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3810\/pgm.2012.01.2521","article-title":"A systematic review of duloxetine for osteoarthritic pain: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?","volume":"124","author":"Citrome","year":"2012","journal-title":"Postgrad Med"},{"issue":"7","key":"2020061911392410100_B99","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/pme.12800","article-title":"Efficacy and safety of duloxetine on osteoarthritis knee pain: a meta-analysis of randomized controlled trials","volume":"16","author":"Wang","year":"2015","journal-title":"Pain Med"},{"key":"2020061911392410100_B100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2474-15-76","article-title":"The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis","volume":"15","author":"Myers","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"issue":"10","key":"2020061911392410100_B101","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.joca.2019.05.002","article-title":"A systematic review of estimates of the minimal clinically important difference and patient acceptable symptom state of the Western Ontario and McMaster Universities Osteoarthritis Index in patients who underwent total hip and total knee replacement","volume":"27","author":"MacKay","year":"2019","journal-title":"Osteoarthritis Cartilage"},{"issue":"20","key":"2020061911392410100_B102","doi-asserted-by":"crossref","first-page":"e3585","DOI":"10.1097\/MD.0000000000003585","article-title":"Efficacy and safety of celecoxib therapy in osteoarthritis: a meta-analysis of randomized controlled trials","volume":"95","author":"Xu","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"2020061911392410100_B103","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1136\/annrheumdis-2015-208387","article-title":"Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials","volume":"75","author":"Zou","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2020061911392410100_B104","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/14397595.2018.1439694","article-title":"Comparative effectiveness of oral pharmacologic interventions for knee osteoarthritis: a network meta-analysis","volume":"28","author":"Jung","year":"2018","journal-title":"Mod Rheumatol"},{"issue":"10090","key":"2020061911392410100_B105","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S0140-6736(17)31744-0","article-title":"Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis","volume":"390","author":"da Costa","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"2020061911392410100_B106","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7326\/M14-1231","article-title":"Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis","volume":"162","author":"Bannuru","year":"2015","journal-title":"Ann Intern Med"},{"key":"2020061911392410100_B107","doi-asserted-by":"crossref","first-page":"h1225","DOI":"10.1136\/bmj.h1225","article-title":"Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials","volume":"350","author":"Machado","year":"2015","journal-title":"BMJ"},{"issue":"6","key":"2020061911392410100_B108","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.joca.2016.01.135","article-title":"Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review","volume":"24","author":"Smith","year":"2016","journal-title":"Osteoarthritis Cartilage"},{"issue":"24","key":"2020061911392410100_B109","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1001\/jama.2018.19319","article-title":"Association of pharmacological treatments with long-term pain control in patients with knee osteoarthritis: a systematic review and meta-analysis","volume":"320","author":"Gregori","year":"2018","journal-title":"JAMA"},{"issue":"7461","key":"2020061911392410100_B110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/bmj.38159.639028.7C","article-title":"Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials","volume":"329","author":"Lin","year":"2004","journal-title":"BMJ"},{"issue":"15","key":"2020061911392410100_B111","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.297.15.1683","article-title":"Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials","volume":"297","author":"Bridge","year":"2007","journal-title":"JAMA"},{"key":"2020061911392410100_B112","doi-asserted-by":"crossref","first-page":"SI53","DOI":"10.3949\/ccjm.69.Suppl_1.SI53","article-title":"Renal effects of nonselective NSAIDs and coxibs","volume":"69","author":"Weir","year":"2002","journal-title":"Cleve Clin J Med"},{"issue":"25","key":"2020061911392410100_B113","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJM199412223312502","article-title":"Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs","volume":"331","author":"Perneger","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"2020061911392410100_B114","doi-asserted-by":"crossref","first-page":"e187896","DOI":"10.1001\/jamanetworkopen.2018.7896","article-title":"Association of nonsteroidal anti-inflammatory drug prescriptions with kidney disease among active young and middle-aged adults","volume":"2","author":"Nelson","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"11","key":"2020061911392410100_B115","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archinte.168.11.1219","article-title":"Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke","volume":"168","author":"Haag","year":"2008","journal-title":"Arch Intern Med"},{"issue":"6","key":"2020061911392410100_B116","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/art.27412","article-title":"Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding","volume":"62","author":"Mass\u00f3 Gonz\u00e1lez","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2020061911392410100_B117","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/bjh.12019","article-title":"High dose vitamin D therapy for chronic pain in children and adolescents with sickle cell disease: results of a randomized double blind pilot study","volume":"159","author":"Osunkwo","year":"2012","journal-title":"Br J Haematol"},{"issue":"6","key":"2020061911392410100_B118","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.pmn.2017.07.003","article-title":"Management of sickle cell pain using pregabalin: a pilot study","volume":"18","author":"Schlaeger","year":"2017","journal-title":"Pain Manag Nurs"},{"issue":"1","key":"2020061911392410100_B119","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajh.21873","article-title":"Pain management in children and adolescents with sickle cell disease","volume":"86","author":"Jerrell","year":"2011","journal-title":"Am J Hematol"},{"issue":"8","key":"2020061911392410100_B120","first-page":"CD012536","article-title":"Antiepileptic drugs for chronic non-cancer pain in children and adolescents","volume":"8","author":"Cooper","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2020061911392410100_B121","first-page":"CD010292","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome","author":"H\u00e4user","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2020061911392410100_B122","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/11598970-000000000-00000","article-title":"The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis","volume":"26","author":"H\u00e4user","year":"2012","journal-title":"CNS Drugs"},{"key":"2020061911392410100_B123","first-page":"CD011790","article-title":"Pregabalin for pain in fibromyalgia in adults","volume":"9","author":"Derry","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2020061911392410100_B124","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12969-016-0106-4","article-title":"Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study","volume":"14","author":"Arnold","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"2020061911392410100_B125","unstructured":"US Food and Drug Administration. Suicidality in children and adolescents being treated with antidepressant medications. Available at: https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/suicidality-children-and-adolescents-being-treated-antidepressant-medications. Accessed 12 August 2019."},{"issue":"6","key":"2020061911392410100_B126","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/AJP.0000000000000183","article-title":"Changes in coping, pain, and activity after cognitive-behavioral training: a randomized clinical trial for pediatric sickle cell disease using smartphones","volume":"31","author":"Schatz","year":"2015","journal-title":"Clin J Pain"},{"issue":"7","key":"2020061911392410100_B127","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/MPH.0b013e3181e793f9","article-title":"A family-based randomized controlled trial of pain intervention for adolescents with sickle cell disease","volume":"32","author":"Barakat","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"2020061911392410100_B128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1348\/135910799168588","article-title":"Cognitive-behaviour therapy for the management of sickle cell disease pain: an evaluation of a community-based intervention","volume":"4","author":"Thomas","year":"1999","journal-title":"Br J Health Psychol"},{"issue":"1","key":"2020061911392410100_B129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1037\/0278-6133.19.1.85","article-title":"Follow-up of coping skills training in adults with sickle cell disease: analysis of daily pain and coping practice diaries","volume":"19","author":"Gil","year":"2000","journal-title":"Health Psychol"},{"issue":"4","key":"2020061911392410100_B130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.apnr.2014.12.005","article-title":"Outcome results of self-efficacy in children with sickle disease pain who were trained to use guided imagery","volume":"28","author":"Dobson","year":"2015","journal-title":"Appl Nurs Res"},{"issue":"4","key":"2020061911392410100_B131","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/00207149708416141","article-title":"Self-hypnosis training as an adjunctive treatment in the management of pain associated with sickle cell disease","volume":"45","author":"Dinges","year":"1997","journal-title":"Int J Clin Exp Hypn"},{"issue":"5","key":"2020061911392410100_B132","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MPH.0b013e318253f0ba","article-title":"Single-session biofeedback-assisted relaxation training in children with sickle cell disease","volume":"34","author":"Myrvik","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"2020061911392410100_B133","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/PHM.0000000000000615","article-title":"The effectiveness of technology-supported exercise therapy for low back pain: a systematic review","volume":"96","author":"Matheve","year":"2017","journal-title":"Am J Phys Med Rehabil"},{"issue":"8","key":"2020061911392410100_B134","doi-asserted-by":"crossref","first-page":"e0134192","DOI":"10.1371\/journal.pone.0134192","article-title":"The effectiveness of cognitive behavioural treatment for non-specific low back pain: a systematic review and meta-analysis","volume":"10","author":"Richmond","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"2020061911392410100_B135","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3899\/jrheum.100104","article-title":"Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome - a systematic review and metaanalysis of randomized controlled trials","volume":"37","author":"Bernardy","year":"2010","journal-title":"J Rheumatol"},{"issue":"635","key":"2020061911392410100_B136","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.3399\/bjgp15X685297","article-title":"Does mindfulness improve outcomes in patients with chronic pain? Systematic review and meta-analysis","volume":"65","author":"Bawa","year":"2015","journal-title":"Br J Gen Pract"},{"issue":"1","key":"2020061911392410100_B137","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12529-016-9572-9","article-title":"Efficacy of biofeedback in chronic back pain: a meta-analysis","volume":"24","author":"Sielski","year":"2017","journal-title":"Int J Behav Med"},{"key":"2020061911392410100_B138","first-page":"203","article-title":"Adjunctive approaches for sickle cell chronic pain","volume":"5","author":"Myers","year":"1999","journal-title":"Altern Health Pract."},{"issue":"1","key":"2020061911392410100_B139","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF01000078","article-title":"The effectiveness of biofeedback-assisted relaxation in modifying sickle cell crises","volume":"12","author":"Cozzi","year":"1987","journal-title":"Biofeedback Self Regul"},{"issue":"2","key":"2020061911392410100_B140","doi-asserted-by":"crossref","first-page":"e89304","DOI":"10.1371\/journal.pone.0089304","article-title":"Massage therapy for fibromyalgia: a systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"2020061911392410100_B141","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00586-010-1356-3","article-title":"A systematic review on the effectiveness of complementary and alternative medicine for chronic non-specific low-back pain","volume":"19","author":"Rubinstein","year":"2010","journal-title":"Eur Spine J"},{"issue":"2","key":"2020061911392410100_B142","doi-asserted-by":"crossref","first-page":"e0117146","DOI":"10.1371\/journal.pone.0117146","article-title":"Traditional Chinese medicine for neck pain and low back pain: a systematic review and meta-analysis","volume":"10","author":"Yuan","year":"2015","journal-title":"PLoS One"},{"issue":"23","key":"2020061911392410100_B143","doi-asserted-by":"crossref","first-page":"E887","DOI":"10.1097\/BRS.0b013e318186b276","article-title":"Effectiveness of acupuncture for low back pain: a systematic review","volume":"33","author":"Yuan","year":"2008","journal-title":"Spine"},{"issue":"24","key":"2020061911392410100_B144","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1097\/01.brs.0000435025.65564.b7","article-title":"Effectiveness of acupuncture for nonspecific chronic low back pain: a systematic review and meta-analysis","volume":"38","author":"Lam","year":"2013","journal-title":"Spine"},{"issue":"7","key":"2020061911392410100_B145","doi-asserted-by":"crossref","first-page":"e100402","DOI":"10.1371\/journal.pone.0100402","article-title":"The effectiveness of Pilates exercise in people with chronic low back pain: a systematic review","volume":"9","author":"Wells","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"2020061911392410100_B146","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1573403X10666140914155304","article-title":"Exercise for adults with fibromyalgia: an umbrella systematic review with synthesis of best evidence","volume":"10","author":"Bidonde","year":"2014","journal-title":"Curr Rheumatol Rev"},{"issue":"3","key":"2020061911392410100_B147","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/ar3002","article-title":"Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials","volume":"12","author":"H\u00e4user","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"2020061911392410100_B148","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1177\/0269215515570379","article-title":"Exercise interventions for the treatment of chronic low back pain: a systematic review and meta-analysis of randomised controlled trials","volume":"29","author":"Searle","year":"2015","journal-title":"Clin Rehabil"},{"issue":"1","key":"2020061911392410100_B149","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00586-010-1518-3","article-title":"A systematic review on the effectiveness of physical and rehabilitation interventions for chronic non-specific low back pain","volume":"20","author":"van Middelkoop","year":"2011","journal-title":"Eur Spine J"},{"issue":"1","key":"2020061911392410100_B150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2522\/ptj.20080103","article-title":"Motor control exercise for persistent, nonspecific low back pain: a systematic review","volume":"89","author":"Macedo","year":"2009","journal-title":"Phys Ther"},{"key":"2020061911392410100_B151","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/1471-2474-15-416","article-title":"An update of stabilisation exercises for low back pain: a systematic review with meta-analysis","volume":"15","author":"Smith","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"issue":"12","key":"2020061911392410100_B152","doi-asserted-by":"crossref","first-page":"e52082","DOI":"10.1371\/journal.pone.0052082","article-title":"A meta-analysis of core stability exercise versus general exercise for chronic low back pain","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"2020061911392410100_B153","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpain.2015.10.002","article-title":"The impact of opioid risk reduction initiatives on high-dose opioid prescribing for patients on chronic opioid therapy","volume":"17","author":"Von Korff","year":"2016","journal-title":"J Pain"},{"issue":"10","key":"2020061911392410100_B154","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/j.pain.0000000000000631","article-title":"Does association of opioid use with pain and function differ by fibromyalgia or widespread pain status?","volume":"157","author":"Turner","year":"2016","journal-title":"Pain"},{"issue":"10","key":"2020061911392410100_B155","first-page":"CD012299","article-title":"High-dose opioids for chronic non-cancer pain: an overview of Cochrane reviews","volume":"10","author":"Els","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"23","key":"2020061911392410100_B156","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2018.18472","article-title":"Opioids for chronic noncancer pain: a systematic review and meta-analysis","volume":"320","author":"Busse","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"2020061911392410100_B157","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"1","key":"2020061911392410100_B158","first-page":"CD006605","article-title":"Long-term opioid management for chronic noncancer pain","volume":"2010","author":"Noble","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"2020061911392410100_B159","first-page":"CD012538","article-title":"Opioids for chronic non-cancer pain in children and adolescents","volume":"7","author":"Cooper","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2020061911392410100_B160","doi-asserted-by":"crossref","first-page":"E503","DOI":"10.36076\/ppj.2014\/17\/E503","article-title":"Opioid tolerance\u2014a predictor of increased length of stay and higher readmission rates","volume":"17","author":"Gulur","year":"2014","journal-title":"Pain Physician"},{"issue":"3","key":"2020061911392410100_B161","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/2013.jamainternmed.733","article-title":"Opioid dose and risk of road trauma in Canada: a population-based study","volume":"173","author":"Gomes","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"5","key":"2020061911392410100_B162","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/joim.12035","article-title":"Opioid use for noncancer pain and risk of myocardial infarction amongst adults","volume":"273","author":"Li","year":"2013","journal-title":"J Intern Med"},{"issue":"4","key":"2020061911392410100_B163","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/aje\/kwt013","article-title":"Opioid use for noncancer pain and risk of fracture in adults: a nested case-control study using the general practice research database","volume":"178","author":"Li","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"11","key":"2020061911392410100_B164","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/BRS.0b013e3182830482","article-title":"Prescription opioids for back pain and use of medications for erectile dysfunction","volume":"38","author":"Deyo","year":"2013","journal-title":"Spine"},{"issue":"2","key":"2020061911392410100_B165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","article-title":"Opioid prescriptions for chronic pain and overdose: a cohort study","volume":"152","author":"Dunn","year":"2010","journal-title":"Ann Intern Med"},{"issue":"7","key":"2020061911392410100_B166","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archinternmed.2011.117","article-title":"Opioid dose and drug-related mortality in patients with nonmalignant pain","volume":"171","author":"Gomes","year":"2011","journal-title":"Arch Intern Med"},{"issue":"7","key":"2020061911392410100_B167","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/AJP.0000000000000021","article-title":"The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription","volume":"30","author":"Edlund","year":"2014","journal-title":"Clin J Pain"},{"issue":"10","key":"2020061911392410100_B168","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/pm\/pnw074","article-title":"The opioid drug epidemic and sickle cell disease: guilt by association","volume":"17","author":"Ruta","year":"2016","journal-title":"Pain Med"},{"issue":"1","key":"2020061911392410100_B169","first-page":"85","article-title":"Cohort study of the impact of high-dose opioid analgesics on overdose mortality [published correction appears in Pain Med. 2016;17(4):797-798]","volume":"17","author":"Dasgupta","year":"2016","journal-title":"Pain Med"},{"issue":"2","key":"2020061911392410100_B170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/1715163518754918","article-title":"Guidance on opioid tapering in the context of chronic pain: evidence, practical advice and frequently asked questions","volume":"151","author":"Murphy","year":"2018","journal-title":"Can Pharm J"},{"issue":"5","key":"2020061911392410100_B171","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jamainternmed.2017.8709","article-title":"Patient-centered prescription opioid tapering in community outpatients with chronic pain","volume":"178","author":"Darnall","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"3","key":"2020061911392410100_B172","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpain.2016.11.003","article-title":"Prescription opioid taper support for outpatients with chronic pain: a randomized controlled trial","volume":"18","author":"Sullivan","year":"2017","journal-title":"J Pain"},{"issue":"6","key":"2020061911392410100_B173","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.mayocp.2015.04.003","article-title":"Tapering long-term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice","volume":"90","author":"Berna","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"2020061911392410100_B174","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AJP.0b013e3182579935","article-title":"Opioid cessation and multidimensional outcomes after interdisciplinary chronic pain treatment","volume":"29","author":"Murphy","year":"2013","journal-title":"Clin J Pain"},{"issue":"8","key":"2020061911392410100_B175","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.pain.2012.03.010","article-title":"Development and validation of shortened, restructured Treatment Outcomes in Pain Survey instrument (the S-TOPS) for assessment of individual pain patients\u2019 health-related quality of life","volume":"153","author":"Haroutiunian","year":"2012","journal-title":"Pain"},{"key":"2020061911392410100_B176","unstructured":"HealthMeasures. Pain domains. Available at: http:\/\/www.healthmeasures.net\/search-view-measures?task=Search.search. Accessed 1 September 2019."},{"issue":"10","key":"2020061911392410100_B177","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/pm\/pnx194","article-title":"Development and validation of an eight-item brief form of the SOAPP-R (SOAPP-8)","volume":"19","author":"Black","year":"2018","journal-title":"Pain Med"},{"issue":"1","key":"2020061911392410100_B178","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/pm\/pnx311","article-title":"Development of a brief version of the Current Opioid Misuse Measure (COMM): the COMM-9","volume":"20","author":"McCaffrey","year":"2019","journal-title":"Pain Med"},{"issue":"4","key":"2020061911392410100_B179","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jpain.2015.12.004","article-title":"Efficacy of the opioid compliance checklist to monitor chronic pain patients receiving opioid therapy in primary care","volume":"17","author":"Jamison","year":"2016","journal-title":"J Pain"},{"issue":"1","key":"2020061911392410100_B180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/13854046.2012.715204","article-title":"Risk factor assessment for problematic use of opioids for chronic pain","volume":"27","author":"Jamison","year":"2013","journal-title":"Clin Neuropsychol"},{"key":"2020061911392410100_B181","first-page":"S111","article-title":"Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse (part 2)","volume":"20","author":"Kaye","year":"2017","journal-title":"Pain Physician"},{"issue":"20","key":"2020061911392410100_B182","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"issue":"3","key":"2020061911392410100_B183","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A phase 3 trial of l-glutamine in sickle cell disease","volume":"379","author":"Niihara","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"2020061911392410100_B184","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"key":"2020061911392410100_B185","author":"National Heart, Lung, and Blood Institute Expert Panel. Evidence-Based Management of Sickle Cell Disease: Expert Panel Report 2014","year":"2014"},{"issue":"11","key":"2020061911392410100_B186","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/ajh.23547","article-title":"Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial","volume":"88","author":"Alvarez","year":"2013","journal-title":"Am J Hematol"},{"issue":"5","key":"2020061911392410100_B187","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2141.2010.08150.x","article-title":"The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults","volume":"149","author":"Kalff","year":"2010","journal-title":"Br J Haematol"},{"issue":"22","key":"2020061911392410100_B188","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM198812013192204","article-title":"Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study","volume":"319","author":"Koshy","year":"1988","journal-title":"N Engl J Med"},{"issue":"8","key":"2020061911392410100_B189","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"2020061911392410100_B190","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mpd.2001.119593","article-title":"Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia","volume":"139","author":"Miller","year":"2001","journal-title":"J Pediatr"},{"issue":"12","key":"2020061911392410100_B191","doi-asserted-by":"crossref","first-page":"e27423","DOI":"10.1002\/pbc.27423","article-title":"Red blood cell transfusion therapy for sickle cell patients with frequent painful events","volume":"65","author":"Hilliard","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"6 pt 1","key":"2020061911392410100_B192","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0022-3476(05)82006-2","article-title":"Effects of a long-term transfusion regimen on sickle cell-related illnesses","volume":"125","author":"Styles","year":"1994","journal-title":"J Pediatr"},{"issue":"10","key":"2020061911392410100_B193","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members [published corrections appear in JAMA. 2014;312(18):1932, JAMA. 2015;313(7):729]","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"2020061911392410100_B194","author":"Benjamin","year":"1999"},{"key":"2020061911392410100_B195","volume-title":"Sickle Cell Acute Painful Episode: Management of an Acute Painful Sickle Cell Episode in Hospital.","author":"Center for Clinical Practice at NICE","year":"2012"},{"issue":"15","key":"2020061911392410100_B196","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"2020061911392410100_B197","unstructured":"American Society of Hematology. CDC issues key clarification on guideline for prescribing opioids for chronic pain. https:\/\/hematology.org\/newsroom\/press-releases\/2019\/cdc-issues-key-clarification-guideline-prescribing-opioids-chronic-pain. Accessed 10 September 2019."},{"key":"2020061911392410100_B198","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.09.009","article-title":"GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT","volume":"81","author":"Sch\u00fcnemann","year":"2017","journal-title":"J Clin Epidemiol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/12\/2656\/1745187\/advancesadv2020001851c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/12\/2656\/1745187\/advancesadv2020001851c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T10:18:35Z","timestamp":1667038715000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/12\/2656\/460974\/American-Society-of-Hematology-2020-guidelines-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":198,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,6,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020001851","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,19]]}}}